Agile Therapeutics, Inc. Accrued Liabilities, Current
Agile Therapeutics, Inc. had Accrued Liabilities, Current of $9.40 million as of 2024-06-30, per its 10-Q filed 2024-08-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2024-08-12
- 2024-06-30: Accrued Liabilities, Current $9.40M.
- 2024-03-31: Accrued Liabilities, Current $8.44M.
- 2023-12-31: Accrued Liabilities, Current $9.13M.
- 2023-09-30: Accrued Liabilities, Current $8.34M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2024-06-30 | $9.40M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $8.44M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $9.13M 10-Q · filed 2024-08-12 | |
| 2023-09-30 | $8.34M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $6.75M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $6.31M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $3.91M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $5.15M 10-K · filed 2023-03-23 | |
| 2022-06-30 | $3.88M 10-K · filed 2023-03-23 | |
| 2022-03-31 | $3.83M 10-K · filed 2023-03-23 | |
| 2021-12-31 | $3.56M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $3.90M 10-Q/A · filed 2021-12-30 | |
| 2021-06-30 | $5.15M 10-Q · filed 2021-07-26 | |
| 2021-03-31 | $2.74M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $3.35M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $2.15M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $1.29M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $649.00K 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $1.80M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $1.11M 10-Q · filed 2019-10-28 | |
| 2019-06-30 | $803.00K 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $483.00K 10-Q · filed 2019-05-03 | |
| 2018-12-31 | $1.34M 10-K · filed 2020-02-20 | |
| 2018-09-30 | $2.02M 10-Q · filed 2018-11-02 | |
| 2018-06-30 | $1.75M 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $1.13M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $852.00K 10-K · filed 2019-03-12 | |
| 2017-09-30 | $1.86M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $1.19M 10-Q · filed 2017-07-28 | |
| 2017-03-31 | $2.57M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $3.64M 10-K · filed 2018-03-12 | $3.35M 10-K · filed 2017-03-15 |
| 2016-09-30 | $1.75M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $1.26M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $1.39M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $2.65M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $2.35M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $2.21M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $1.11M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $1.06M 10-K · filed 2016-03-09 | $1.06M 10-K · filed 2015-03-26 |
| 2014-09-30 | $660.14K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $373.27K 10-Q · filed 2014-08-14 | |
| 2013-12-31 | $379.16K 10-K · filed 2015-03-26 |